Renal Services

Year founded 2007
HQ Location London
Sector Healthcare
Staff count 100
Turnover £10m
The UK’s first privately operated independent chain of kidney dialysis clinics Renal Services was one of BGF’s earliest investments and was chosen as one of the 1000 Companies to inspire Britain 2017.
www.renalservices.com
I am a serial entrepreneur in this space, I’ve been doing this for over 20 years all over the world, but this is my first venture in the UK.

Stefano Ciampolini

Co-founder & CEO

Breaking into a closed market

Co-founder and CEO Stefano Ciampolini is a veteran in providing private sector kidney dialysis clinics. He began his career over 20 years ago in his native Italy and has since opened renal clinics in France, the UK and the US.

In 2007 he saw potential in the UK. “The NHS was having to do more with less – there were no independent private sector providers,” says Ciampolini.


Building trust with skeptics

Back in 2007, Ciampolini explains that it was “almost impossible” for a newcomer to be included in the NHS tender process.

“It was very difficult because sometimes it was adversarial with the NHS because ideologically they did not like private sector service provision,” he says.

I was confident it would work – I’d done it before and in a way the UK was the only country left where this had not happened.

Stefano Ciampolini, Renal Services

Self-funding a test run

With £1m of his own money and private investment from family and friends – Ciampolini bought a small dialysis company, which operated two tiny holiday dialysis clinics in Skegness and the Portsmouth area.

He hired a team made up of “superstar nurses” who had previously worked for the NHS and other companies. “We incentivised them well,” he says. The clinics were pilots with “less than 15 patients each and total revenues of around £300,000”.

“I was confident it would work – I’d done it before and in a way the UK was the only country left where this had not happened,” he says.

And just a few months later Ciampolini was proven right. In the spring of 2007 Renal Services was invited into a tender process for Portsmouth NHS Trust and won it.

“It was a huge morale boost, suddenly we were treating 300 patients across three locations,” he says.


Growth stalled by the crash

By 2009 the company had five clinics with 50 staff. But growth over the following years was slow and funding expansion was a challenge. “Dialysis clinics are capital-intensive,” says Ciampolini, “and everything goes into buildings and equipment.”

The timing was terrible for approaching traditional lenders for growth capital. Ciampolini says that between 2009 and 2012 it was “impossible” to raise money and the result was “we were stuck”.


A tipping point

Then in 2012 came a tipping point. “Everything restarted, there was a wave of new contracts and the NHS realised they could not go it alone,” he says.

But Ciampolini realised he couldn’t go it alone either. What he really needed was the clout of an institutional investor.

In late 2014 he secured £3.1m of growth capital from BGF. He praises the “painless process” of securing the funds. “It was the right time for both of us, so a deal was done in a matter of weeks,” he says.

The company deployed the capital in expanding the number clinics. Today Renal Services generates £10m in revenue from 12 clinics, and four more will be opened by the end of 2018.

But Ciampolini believes his success is down to providing the best care to patients – most of whom come for four hours a day, three times a week. “All our clinics feel more like business class lounges than hospitals with artwork and natural light,” he says, “because after all nobody wants to be reminded of how sick they are.”

Lead Partner Support

BGF

BGF was set up in 2011 to offer growing companies and ambitious entrepreneurs patient capital and strategic support. Today, we are the UK and Ireland’s most active investor in SMEs.

Find out more

Key Metrics

600+/500+

number of patients (regular/holidays)

14

Number of clinics

400,000+

Hours of dialysis provided (annually)

Sources of capital
Supported By

Related Stories

Calcivis
Founder Adam Christie credits early hiring of top talent and funding from Scotland’s Archangels as key to his scale-up success, helping Calcivis to revolutionise dentistry with its novel tool that diagnoses active tooth decay. Read more...
Sphere Fluidics
Sphere Fluidics makes cell-analysis systems to help pharmaceutical companies discover new potential blockbusters, and has raised more than £16m of financial capital and grants in eight years. Read more...
BBOXX
BBOXX's highly scalable solar-powered battery power utilities for people in the developing world have boosted the company’s revenue to $28m, proving that positive social impact can also be a great investment. Read more...
Culture Trip
Venturing into online content where many entrepreneurs fear to tread, Culture Trip's founder and CEO Kris Naudts has adopted the Silicon Valley user-growth model of scaling, winning considerable investor backing. Read more...
Xupes
Pre-owned luxury goods retailer Xupes has scaled from a father and son partnership to a 37-strong team in nine years, thanks to a clever and considerate customer-focused strategy. Read more...
LendInvest
LendInvest has secured a strong position in the UK property finance market after raising £760m of lending capital, and is taking on the established bank market with its technology-driven model and its increasingly diverse and cost-effective capital base. Read more...